Switching to amisulpride due to hepatic complications.
Yagdiran
Oktay
O
University Hospital Eppendorf, Clinic for Psychiatry and Psychotherapy, Martinistr. 52, 20246, Hamburg, Germany. yagdiran@uke.uni-hamburg.de
Haasen
Christian
C
Nika
Evangelia
E
Krausz
Michael
M
Naber
Dieter
D
D000328:Adult; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D005475:Flupenthixol / Q000009:adverse effects*; D006220:Haloperidol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D010464:Perazine / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride; D010464:Perazine; D005475:Flupenthixol; D006220:Haloperidol; C006820:bromperidol